Related Experiment Video
Updated: Aug 11, 2026

10:50
Primary Culture of Human Vestibular Schwannomas
Published on: July 20, 2014
13.2K
Large and small vestibular schwannomas: same, yet different tumors
Satoshi Kiyofuji1,2, Brian A Neff3, Matthew L Carlson3
1Department of Neurosurgery, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 154-0023, Japan. kiyofuji-tky@umin.ac.jp.
Acta Neurochirurgica
|January 20, 2021
Summary
Large vestibular schwannomas (VS) present differently and have more complications than small VS, with worse facial nerve function and hearing outcomes. Tumor control rates were similar for both large and small VS.
Area of Science:
- Neurosurgery
- Otolaryngology
- Oncology
Background:
- Vestibular schwannomas (VS) vary in size and symptoms.
- Treatment strategies differ for large and small VS, with goals of function preservation.
- Understanding presentation and surgical outcomes is crucial for optimal patient management.
Purpose of the Study:
- To compare the clinical presentation and surgical outcomes of large vestibular schwannomas (LTG) versus small vestibular schwannomas (STG).
- To evaluate differences in complications, functional preservation, and tumor control between LTG and STG.
Main Methods:
- Retrospective data collection of surgically treated VS patients.
- Categorization into large tumor group (LTG, ≥4.0 cm) and small tumor group (STG, <1.0 cm).
- Statistical analysis using p < 0.05 to determine significance.
Main Results:
- STG patients more frequently presented with tinnitus and sudden hearing loss.
- LTG had significantly higher rates of subtotal resection (STR), complications, and poorer postoperative facial nerve function and hearing.
- Tumor recurrence/progression rates were not significantly different between LTG and STG.
Conclusions:
- Large and small VS exhibit distinct clinical presentations.
- Despite maximal function-preservation efforts, LTG experienced more unsatisfactory outcomes in facial nerve function and hearing compared to STG.
- Similar tumor control was achieved for both large and small VS.
Related Concept Videos
Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...

